Role of matrix metalloproteinases in kidney development and glomerulopathy: lessons from transgenic mice

Brigitte Lelongt1, Pierre Ronco

  • 1Unité INSERM 489 and Université Paris 6, Hôpital Tenon, Paris, France.

Insights

Matrix metalloproteinase-9 (MMP9) deficiency reduces nephron mass and impairs renal function in aging mice. MMP9 also protects against severe glomerulonephritis by degrading fibrin deposits.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • Matrix metalloproteinase-9 (MMP9) plays a role in renal organogenesis and is implicated in nephropathies.
  • The in vivo function of MMP9 in adult kidney health and disease is not fully understood.

Purpose of the Study:

  • To investigate the renal phenotype of MMP9-deficient mice.
  • To assess the susceptibility of MMP9-deficient mice to a murine model of proliferative glomerulonephritis.

Main Methods:

  • Analysis of renal phenotype in MMP9-deficient mice.
  • Induction of a murine model of proliferative glomerulonephritis.

Main Results:

  • MMP9 deficiency led to a 12% reduction in nephron mass in adult mice.
  • MMP9-deficient mice exhibited normal renal function and histology up to 12 months, with lesions appearing thereafter.
  • Glomerulonephritis was more severe in MMP9-deficient mice, characterized by increased crescent formation and fibrin deposition.
  • Fibrin was identified as a critical substrate for MMP9.

Conclusions:

  • MMP9 is essential for nephron mass formation and renal function in aging mice.
  • MMP9 has a protective role against the development of fibrin-induced glomerular lesions in glomerulonephritis.